InnoTherapy Inc (246960) — Capital Reinvestment Ratio
Latest as of June 2025:
2.80x
InnoTherapy Inc (246960) has a Capital Reinvestment Ratio of 2.80x as of June 2025, meaning it reinvests 3% of its operating cash flow (₩131.12 Million) in capital expenditures (₩367.29 Million). Check how tangible is InnoTherapy Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
2.80x
Capex / Operating Cash Flow
Operating Cash Flow
₩131.12 Million
KRW
Capital Expenditures
₩367.29 Million
KRW
Data as of
Jun 2025
Most recent filing
Annual Capital Reinvestment Ratio for InnoTherapy Inc (None–None)
Year-by-year Capital Reinvestment Ratio for InnoTherapy Inc from None to None. See 246960 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow